Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mills

Showing results (761-770 of 1,398) with videos related to

Pageof 140
Sort By:
Nature Communications|October 3, 2020
Multi-omics prediction of immune-related adverse events during checkpoint immunotherapyYing Jing, Jin Liu, Youqiong Ye, et al.
Cell Reports|May 17, 2018
Defective Replication Stress Response Is Inherently Linked to the Cancer Stem Cell PhenotypeDaniel J McGrail, Curtis Chun-Jen Lin, Hui Dai, et al.
The Journal of Biological Chemistry|July 19, 2003
Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascadesYiling Lu, Qinghua Yu, Jue Hui Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2018
Modulation of the Hippo pathway and organ growth by RNA processing proteinsJana Mach, Mardelle Atkins, Kathleen M Gajewski, et al.
Cancer Cell|April 7, 2009
Rak functions as a tumor suppressor by regulating PTEN protein stability and functionEun-Kyoung Yim, Guang Peng, Hui Dai, et al.
Cancer Research|May 2, 2013
Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8Zachary C Hartman, Graham M Poage, Petra den Hollander, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2013
Proteomic markers of DNA repair and PI3K pathway activation predict response to the PARP inhibitor BMN 673 in small cell lung cancerRobert J Cardnell, Ying Feng, Lixia Diao, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
Transcriptional and phenotypic heterogeneity underpinning venetoclax resistance in AMLVakul Mohanty, Natalia Baran, Yuefan Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2012
cMET and phospho-cMET protein levels in breast cancers and survival outcomesKanwal P Raghav, Wenting Wang, Shuying Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2010
CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesisGong Yang, Daniel G Rosen, Guangzhi Liu, et al.
Pageof 140

Showing results (761-770 of 1,398) with videos related to

Sort By:
Pageof 140
Nature Communications|October 3, 2020
Multi-omics prediction of immune-related adverse events during checkpoint immunotherapyYing Jing, Jin Liu, Youqiong Ye, et al.
Cell Reports|May 17, 2018
Defective Replication Stress Response Is Inherently Linked to the Cancer Stem Cell PhenotypeDaniel J McGrail, Curtis Chun-Jen Lin, Hui Dai, et al.
The Journal of Biological Chemistry|July 19, 2003
Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascadesYiling Lu, Qinghua Yu, Jue Hui Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2018
Modulation of the Hippo pathway and organ growth by RNA processing proteinsJana Mach, Mardelle Atkins, Kathleen M Gajewski, et al.
Cancer Cell|April 7, 2009
Rak functions as a tumor suppressor by regulating PTEN protein stability and functionEun-Kyoung Yim, Guang Peng, Hui Dai, et al.
Cancer Research|May 2, 2013
Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8Zachary C Hartman, Graham M Poage, Petra den Hollander, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2013
Proteomic markers of DNA repair and PI3K pathway activation predict response to the PARP inhibitor BMN 673 in small cell lung cancerRobert J Cardnell, Ying Feng, Lixia Diao, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
Transcriptional and phenotypic heterogeneity underpinning venetoclax resistance in AMLVakul Mohanty, Natalia Baran, Yuefan Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2012
cMET and phospho-cMET protein levels in breast cancers and survival outcomesKanwal P Raghav, Wenting Wang, Shuying Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2010
CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesisGong Yang, Daniel G Rosen, Guangzhi Liu, et al.
Pageof 140